Latest articlesAll articles
A Review of the Latest Advancements in Ovarian Cancer Care Featured at ESMO 2022
Marantic Endocarditis and Lung Adenocarcinoma with Brain Metastasis: A Diagnostic Conundrum
Congress reviewsAll congress reviews
Review of the European Society for Medical Oncology (ESMO) Congress 2022
THREE years after the last in-person European Society for Medical Oncology (ESMO) Congress, the 2022 congress welcomed nearly 23,000 participants in Paris, France, as well as 5,000 online. The purpose of the congress was a celebration of being back together, and of collaboration between all healthcare professionals wanting to improve survival times for patients.
Immunotherapy in Non-small Cell Lung Cancer: Current and Future Use
EXPLORING the current state of use of immunotherapies in the treatment of non-small cell lung cancer (NSCLC) and looking to future immunotherapeutic pathways, three expert speakers presented a session at European Society for Medical Oncology (ESMO) Congress 2022, on the 12th of September.
Tumour Organoids from Multifocal Metastatic Colorectal Cancers for Personalised Oncology
Does Hepatitis C Independently Increase the Risk of Colorectal Adenoma?
Latest NewsAll News
Latest PodcastsAll Podcasts
19th January 2023
The Emerging Role of HRD Testing and the Progress of PARP Inhibitors in Ovarian Cancer
In this EMJ podcast episode, David O’Malley, Director of Gynecologic Oncology, Ohio State University, and the James Comprehensive Cancer Center, Columbus, Ohio, USA, and Christina Fotopoulou, Consultant Gynaecological Oncologist…